{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:16:28Z","timestamp":1790691388759,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,29]],"date-time":"2018-01-29T00:00:00Z","timestamp":1517184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,1,29]],"date-time":"2018-01-29T00:00:00Z","timestamp":1517184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Farber Disease (FD) is an ultra-rare Lysosomal Storage Disorder caused by deficient acid ceramidase (ACDase) activity. Patients with ACDase deficiency manifest a spectrum of symptoms including formation of nodules, painful joints, and a hoarse voice. Classic FD patients will develop histiocytes in organs and die in childhood. Monocyte chemotactic protein (MCP-1; CCL2) is significantly elevated in both FD patients and a mouse model we previously generated. Here, to further study MCP-1 in FD, we created an ACDase;MCP-1 double mutant mouse. We show that deletion of MCP-1 reduced leukocytosis, delayed weight loss, and improved lifespan. Reduced inflammation and fibrosis were observed in livers from double mutant animals. Bronchial alveolar lavage fluid analyses revealed a reduction in cellular infiltrates and protein accumulation. Furthermore, reduced sphingolipid accumulation was observed in the lung and liver but not in the brain. The neurological and hematopoietic defects observed in FD mice were maintained. A compensatory cytokine response was found in the double mutants, however, that may contribute to continued signs of inflammation and injury. Taken together, targeting a reduction of MCP-1 opens the door to a better understanding of the mechanistic consequences of ceramide accumulation and may even delay the progression of FD in some organ systems.<\/jats:p>","DOI":"10.1038\/s41598-018-20052-6","type":"journal-article","created":{"date-parts":[[2018,1,23]],"date-time":"2018-01-23T15:24:11Z","timestamp":1516721051000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Deletion of MCP-1 Impedes Pathogenesis of Acid Ceramidase Deficiency"],"prefix":"10.1038","volume":"8","author":[{"given":"Fabian P. S.","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaalee","family":"Dworski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Medin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,29]]},"reference":[{"key":"20052_CR1","unstructured":"Levade, T., Sandhoff, K., Schulze, H. & Medin, J. In Scriver\u2019s OMMBID (Online Metabolic and Molecular Bses of Inherited Diseases) eds Valle, D., Beaudet, A. L., Vogelstein, B., Kinzler, K. W., Antonarakis, S. E., Ballabio, A. (McGraw-Hill, New York, 2014)."},{"key":"20052_CR2","first-page":"67","volume":"19","author":"A Ahmad","year":"2009","unstructured":"Ahmad, A., Mazhar, A. U. & Anwar, M. Farber disease: a rare neurodegenerative disorder. J Coll Physicians Surg Pak. 19, 67\u201368 (2009).","journal-title":"J Coll Physicians Surg Pak"},{"key":"20052_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1546-0096-5-15","volume":"5","author":"K Ehlert","year":"2007","unstructured":"Ehlert, K. et al. Farber disease: clinical presentation, pathogenesis and a new approach to treatment. Pediatr Rheumatol Online J. 5, 15 (2007).","journal-title":"Pediatr Rheumatol Online J."},{"key":"20052_CR4","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/emmm.201202301","volume":"5","author":"AM Alayoubi","year":"2013","unstructured":"Alayoubi, A. M. et al. Systemic ceramide accumulation leads to severe and varied pathological consequences. EMBO Mol Med. 5, 827\u2013842 (2013).","journal-title":"EMBO Mol Med"},{"key":"20052_CR5","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1006\/geno.1999.5940","volume":"62","author":"C Li","year":"1999","unstructured":"Li, C. et al. The human acid ceramidase gene (ASAH): structure, chromosomal location, mutation analysis, and expression. Genomics 62, 223\u2013231 (1999).","journal-title":"Genomics"},{"key":"20052_CR6","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.bbadis.2016.11.031","volume":"1863","author":"S Dworski","year":"2017","unstructured":"Dworski, S. et al. Acid Ceramidase Deficiency is characterized by a unique plasma cytokine and ceramide profile that is altered by therapy. Biochim Biophys Acta 1863, 386\u2013394 (2017).","journal-title":"Biochim Biophys Acta"},{"key":"20052_CR7","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1089\/jir.2008.0027","volume":"29","author":"SL Deshmane","year":"2009","unstructured":"Deshmane, S. L., Kremlev, S., Amini, S. & Sawaya, B. E. Monocyte chemoattractant protein-1 (MCP-1): an overview. J. Interferon Cytokine Res.\u00a029, 313\u2013326 (2009).","journal-title":"Journal of interferon & cytokine research"},{"key":"20052_CR8","doi-asserted-by":"publisher","first-page":"5134","DOI":"10.1073\/pnas.87.13.5134","volume":"87","author":"SD Cushing","year":"1990","unstructured":"Cushing, S. D. et al. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc. Natl. Acad. Sci. USA 87, 5134\u20135138 (1990).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"20052_CR9","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.4049\/jimmunol.155.3.1515","volume":"155","author":"TJ Standiford","year":"1995","unstructured":"Standiford, T. J. et al. Macrophage inflammatory protein-1 alpha mediates lung leukocyte recruitment, lung capillary leak, and early mortality in murine endotoxemia. J. Immunol. 155, 1515\u20131524 (1995).","journal-title":"J. Immunol."},{"key":"20052_CR10","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.4049\/jimmunol.142.6.1956","volume":"142","author":"T Yoshimura","year":"1989","unstructured":"Yoshimura, T., Robinson, E. A., Tanaka, S., Appella, E. & Leonard, E. J. Purification and amino acid analysis of two human monocyte chemoattractants produced by phytohemagglutinin-stimulated human blood mononuclear leukocytes. J. Immunol. 142, 1956\u20131962 (1989).","journal-title":"J. Immunol."},{"key":"20052_CR11","first-page":"S116","volume":"19","author":"S Saygi","year":"2015","unstructured":"Saygi, S., Haytoglu, Z., Savas, T., Alkan, O. & Erol, I. P78\u20132554: Farber disease in a child with a novel homozygous c. 92G\u2009>\u2009T mutation. Eur. J. Paediatr. Neurol.\u00a019, S116 (2015).","journal-title":"European Journal of Paediatric Neurology"},{"key":"20052_CR12","doi-asserted-by":"publisher","first-page":"e162","DOI":"10.3324\/haematol.2014.108530","volume":"100","author":"S Dworski","year":"2015","unstructured":"Dworski, S. et al. Markedly perturbed hematopoiesis in acid ceramidase deficient mice. Haematologica. 100, e162\u20135 (2015).","journal-title":"Haematologica"},{"key":"20052_CR13","doi-asserted-by":"crossref","unstructured":"He, X. et al. Enzyme replacement therapy for Farber disease: Proof-of-concept studies in cells and mice. BBA Clinc. (2017).","DOI":"10.1016\/j.bbacli.2017.02.001"},{"key":"20052_CR14","doi-asserted-by":"crossref","unstructured":"Yeager, A. et al. Bone marrow transplantation for infantile ceramidase deficiency (Farber disease). Bone Marrow Transplant. 26 (2000).","DOI":"10.1038\/sj.bmt.1702489"},{"key":"20052_CR15","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jpeds.2003.09.051","volume":"144","author":"J Vormoor","year":"2004","unstructured":"Vormoor, J. et al. Successful hematopoietic stem cell transplantation in Farber disease. J. Pediatr. 144, 132\u2013134 (2004).","journal-title":"J. Pediatr."},{"key":"20052_CR16","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1016\/j.ymgme.2015.12.345","volume":"117","author":"L Lopez-Vasquez","year":"2016","unstructured":"Lopez-Vasquez, L. et al. Acid ceramidase deficiency leads to multiple skin abnormalities in a mouse model of Farber disease. Mol. Genet. Metab. 117, S75\u2013S76 (2016).","journal-title":"Mol. Genet. Metab."},{"key":"20052_CR17","doi-asserted-by":"crossref","unstructured":"Yu, F. P. et al. Chronic lung injury and impaired pulmonary function in a mouse model of acid ceramidase deficiency. Am. J. Physiol. Lung Cell Mol. doi: 10.1152\/ajplung.00223.2017. (2017).","DOI":"10.1152\/ajplung.00223.2017"},{"key":"20052_CR18","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.ajpath.2016.12.005","volume":"187","author":"J Sikora","year":"2017","unstructured":"Sikora, J. et al. Acid Ceramidase Deficiency in Mice Results in a Broad Range of Central Nervous System Abnormalities. Am. J. Pathol.\u00a0\u00a0187, 864\u2013883 (2017).","journal-title":"The American Journal of Pathology"},{"key":"20052_CR19","doi-asserted-by":"publisher","first-page":"e4112","DOI":"10.1371\/journal.pone.0004112","volume":"4","author":"P Vogel","year":"2009","unstructured":"Vogel, P. et al. Incomplete inhibition of sphingosine 1-phosphate lyase modulates immune system function yet prevents early lethality and non-lymphoid lesions. PloS one 4, e4112 (2009).","journal-title":"PloS one"},{"key":"20052_CR20","doi-asserted-by":"publisher","first-page":"4292","DOI":"10.4049\/jimmunol.0901724","volume":"183","author":"C Weber","year":"2009","unstructured":"Weber, C. et al. Discontinued postnatal thymocyte development in sphingosine 1-phosphate-lyase-deficient mice. J. Immunol. 183, 4292\u20134301 (2009).","journal-title":"J. Immunol."},{"key":"20052_CR21","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/S0016-5085(03)01213-7","volume":"125","author":"M M\u00fchlbauer","year":"2003","unstructured":"M\u00fchlbauer, M. et al. A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease. Gastroenterology 125, 1085\u20131093 (2003).","journal-title":"Gastroenterology"},{"key":"20052_CR22","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1136\/gutjnl-2011-300304","volume":"61","author":"C Baeck","year":"2012","unstructured":"Baeck, C. et al. Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury. Gut 61, 416\u2013426 (2012).","journal-title":"Gut"},{"key":"20052_CR23","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1161\/CIRCGENETICS.111.959981","volume":"4","author":"YA Chiao","year":"2011","unstructured":"Chiao, Y. A. et al. Multi-analyte profiling reveals matrix metalloproteinase-9 and monocyte chemotactic protein-1 as plasma biomarkers of cardiac aging. Circ. Cardiovasc. Genet. 4, 455\u2013462 (2011).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"20052_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-2-19","volume":"2","author":"M Ruhwald","year":"2009","unstructured":"Ruhwald, M., Bjerregaard-Andersen, M., Rabna, P., Eugen-Olsen, J. & Ravn, P. IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay. BMC research notes 2, 19 (2009).","journal-title":"BMC research notes"},{"key":"20052_CR25","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1165\/rcmb.2011-0392TR","volume":"46","author":"M Bhatia","year":"2012","unstructured":"Bhatia, M., Zemans, R. L. & Jeyaseelan, S. Role of chemokines in the pathogenesis of acute lung injury. Am. J. Respir. Cell. Mol. Biol.\u00a046, 566\u2013572 (2012).","journal-title":"American journal of respiratory cell and molecular biology"},{"key":"20052_CR26","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1034\/j.1399-3003.1999.14b23.x","volume":"14","author":"M Suga","year":"1999","unstructured":"Suga, M. et al. Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases. Eur. Respir. J. 14, 376\u2013382 (1999).","journal-title":"Eur. Respir. J."},{"key":"20052_CR27","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1183\/09031936.99.14238399","volume":"14","author":"K Iyonaga","year":"1999","unstructured":"Iyonaga, K. et al. Elevated bronchoalveolar concentrations of MCP\u20101 in patients with pulmonary alveolar proteinosis. Eur. Respir. J. 14, 383\u2013389 (1999).","journal-title":"Eur Respir J."},{"key":"20052_CR28","first-page":"396","volume":"69","author":"CM Flory","year":"1993","unstructured":"Flory, C. M., Jones, M. L. & Warren, J. S. Pulmonary granuloma formation in the rat is partially dependent on monocyte chemoattractant protein 1. Lab. Invest. 69, 396\u2013404 (1993).","journal-title":"Lab. Invest."},{"key":"20052_CR29","doi-asserted-by":"publisher","first-page":"8425","DOI":"10.1073\/pnas.0400625101","volume":"101","author":"YP Wu","year":"2004","unstructured":"Wu, Y. P. & Proia, R. L. Deletion of macrophage-inflammatory protein 1 alpha retards neurodegeneration in Sandhoff disease mice. Proc. Natl. Acad. Sci. USA 101, 8425\u20138430 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"20052_CR30","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1093\/hmg\/dds126","volume":"21","author":"ME Lopez","year":"2012","unstructured":"Lopez, M. E., Klein, A. D., Hong, J., Dimbil, U. J. & Scott, M. P. Neuronal and epithelial cell rescue resolves chronic systemic inflammation in the lipid storage disorder Niemann-Pick C. Hum. Mol. Genet. 21, 2946\u20132960 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"20052_CR31","doi-asserted-by":"publisher","first-page":"3610","DOI":"10.1523\/JNEUROSCI.6344-10.2011","volume":"31","author":"Y Kondo","year":"2011","unstructured":"Kondo, Y., Adams, J. M., Vanier, M. T. & Duncan, I. D. Macrophages counteract demyelination in a mouse model of globoid cell leukodystrophy. J. Neurosci. 31, 3610\u20133624 (2011).","journal-title":"J. Neurosci."},{"key":"20052_CR32","doi-asserted-by":"crossref","unstructured":"van Doorn, R. et al. Fingolimod attenuates ceramide-induced blood\u2013brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes. Acta Neuropathol., 1\u201314 (2012).","DOI":"10.1007\/s00401-012-1014-4"},{"key":"20052_CR33","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.bbadis.2007.04.002","volume":"1772","author":"MJ Van Breemen","year":"2007","unstructured":"Van Breemen, M. J. et al. Increased plasma macrophage inflammatory protein (MIP)-1\u03b1 and MIP-1\u03b2 levels in type 1 Gaucher disease. Biochim. Biophys. Acta 1772, 788\u2013796 (2007).","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease"},{"key":"20052_CR34","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/j.1365-2141.2004.05351.x","volume":"129","author":"M Jmoudiak","year":"2005","unstructured":"Jmoudiak, M. & Futerman, A. H. Gaucher disease: pathological mechanisms and modern management. Br. J. Haematol. 129, 178\u2013188 (2005).","journal-title":"Br. J. Haematol."},{"key":"20052_CR35","doi-asserted-by":"publisher","first-page":"19473","DOI":"10.1073\/pnas.1003308107","volume":"107","author":"PK Mistry","year":"2010","unstructured":"Mistry, P. K. et al. Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage. Proc. Natl. Acad. Sci. USA 107, 19473\u201319478 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"20052_CR36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.bcmd.2010.10.010","volume":"46","author":"EV Pavlova","year":"2011","unstructured":"Pavlova, E. V. et al. Potential biomarkers of osteonecrosis in Gaucher disease. Blood Cells Mol. Dis.\u00a046, 27\u201333 (2011).","journal-title":"Blood Cells, Molecules, and Diseases"},{"key":"20052_CR37","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/09629350210313","volume":"11","author":"FR Homaidan","year":"2002","unstructured":"Homaidan, F. R., El-Sabban, M. E., Chakroun, I., El-Sibai, M. & Dbaibo, G. S. IL-1 stimulates ceramide accumulation without inducing apoptosis in intestinal epithelial cells. Mediators Inflamm. 11, 39\u201345 (2002).","journal-title":"Mediators Inflamm."},{"key":"20052_CR38","doi-asserted-by":"crossref","first-page":"6511","DOI":"10.4049\/jimmunol.154.12.6511","volume":"154","author":"C Franci","year":"1995","unstructured":"Franci, C., Wong, L. M., Van Damme, J., Proost, P. & Charo, I. F. Monocyte chemoattractant protein-3, but not monocyte chemoattractant protein-2, is a functional ligand of the human monocyte chemoattractant protein-1 receptor. J. Immunol. 154, 6511\u20136517 (1995).","journal-title":"J. Immunol."},{"key":"20052_CR39","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1084\/jem.185.1.99","volume":"185","author":"MN Sarafi","year":"1997","unstructured":"Sarafi, M. N., Garcia-Zepeda, E. A., MacLean, J. A., Charo, I. F. & Luster, A. D. Murine monocyte chemoattractant protein (MCP)-5: a novel CC chemokine that is a structural and functional homologue of human MCP-1. J. Exp. Med. 185, 99\u2013109 (1997).","journal-title":"J. Exp. Med."},{"key":"20052_CR40","doi-asserted-by":"publisher","first-page":"6846","DOI":"10.4049\/jimmunol.180.10.6846","volume":"180","author":"T Jia","year":"2008","unstructured":"Jia, T. et al. Additive roles for MCP-1 and MCP-3 in CCR2-mediated recruitment of inflammatory monocytes during Listeria monocytogenes infection. J. Immunol. 180, 6846\u20136853 (2008).","journal-title":"J. Immunol."},{"key":"20052_CR41","doi-asserted-by":"publisher","first-page":"16404","DOI":"10.1074\/jbc.272.26.16404","volume":"272","author":"TA Berkhout","year":"1997","unstructured":"Berkhout, T. A. et al. Cloning, in vitro expression, and functional characterization of a novel human CC chemokine of the monocyte chemotactic protein (MCP) family (MCP-4) that binds and signals through the CC chemokine receptor 2B. J. Biol. Chem. 272, 16404\u201316413 (1997).","journal-title":"J. Biol. Chem."},{"key":"20052_CR42","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.1093\/hmg\/ddq269","volume":"19","author":"J Groh","year":"2010","unstructured":"Groh, J. et al. Attenuation of MCP-1\/CCL2 expression ameliorates neuropathy in a mouse model for Charcot\u2013Marie\u2013Tooth 1X. Hum. Mol. Genet. 19, 3530\u20133543 (2010).","journal-title":"Hum. Mol. Genet."},{"key":"20052_CR43","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.2353\/ajpath.2010.090694","volume":"176","author":"B Kohl","year":"2010","unstructured":"Kohl, B., Fischer, S., Groh, J., Wessig, C. & Martini, R. MCP-1\/CCL2 modifies axon properties in a PMP22-overexpressing mouse model for Charcot-Marie-Tooth 1A neuropathy. Am. J. Pathol. 176, 1390\u20131399 (2010).","journal-title":"The American journal of pathology"},{"key":"20052_CR44","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0021-9150(98)00318-9","volume":"143","author":"TC Dawson","year":"1999","unstructured":"Dawson, T. C., Kuziel, W. A., Osahar, T. A. & Maeda, N. Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis 143, 205\u2013211 (1999).","journal-title":"Atherosclerosis"},{"key":"20052_CR45","doi-asserted-by":"publisher","first-page":"F697","DOI":"10.1152\/ajprenal.00016.2008","volume":"294","author":"GH Tesch","year":"2008","unstructured":"Tesch, G. H. MCP-1\/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy. Am. J. Physiol. Renal Physiol. 294, F697\u2013701 (2008).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"20052_CR46","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1042\/CS20080581","volume":"117","author":"J Niu","year":"2009","unstructured":"Niu, J. & Kolattukudy, P. E. Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications. Clin. Sci. (Lond) 117, 95\u2013109 (2009).","journal-title":"Clin. Sci. (Lond)"},{"key":"20052_CR47","doi-asserted-by":"publisher","first-page":"G1259","DOI":"10.1152\/ajpgi.00435.2004","volume":"288","author":"M Bhatia","year":"2005","unstructured":"Bhatia, M., Ramnath, R. D., Chevali, L. & Guglielmotti, A. Treatment with bindarit, a blocker of MCP-1 synthesis, protects mice against acute pancreatitis. Am. J. Physiol. Gastrointest. Liver Physiol. 288, G1259\u201365 (2005).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"20052_CR48","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1159\/000369149","volume":"129","author":"C Zoja","year":"2015","unstructured":"Zoja, C. et al. Effects of MCP-1 inhibition by bindarit therapy in a rat model of polycystic kidney disease. Nephron 129, 52\u201361 (2015).","journal-title":"Nephron"},{"key":"20052_CR49","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.pharmthera.2006.04.004","volume":"112","author":"M El Alwani","year":"2006","unstructured":"El Alwani, M., Wu, B. X., Obeid, L. M. & Hannun, Y. A. Bioactive sphingolipids in the modulation of the inflammatory response. Pharmacol. Ther. 112, 171\u2013183 (2006).","journal-title":"Pharmacol. Ther."},{"key":"20052_CR50","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nature13475","volume":"510","author":"M Maceyka","year":"2014","unstructured":"Maceyka, M. & Spiegel, S. Sphingolipid metabolites in inflammatory disease. Nature 510, 58\u201367 (2014).","journal-title":"Nature"},{"key":"20052_CR51","doi-asserted-by":"publisher","first-page":"E1213","DOI":"10.1152\/ajpendo.00480.2012","volume":"304","author":"L Arana","year":"2013","unstructured":"Arana, L. et al. Ceramide 1-phosphate induces macrophage chemoattractant protein-1 release: involvement in ceramide 1-phosphate-stimulated cell migration. Am. J. Physiol. Endocrinol. Metab. 304, E1213\u201326 (2013).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"20052_CR52","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.jnutbio.2014.07.008","volume":"25","author":"Y Hamada","year":"2014","unstructured":"Hamada, Y. et al. Involvement of de novo ceramide synthesis in pro-inflammatory adipokine secretion and adipocyte\u2013macrophage interaction. J. Nutr. Biochem. 25, 1309\u20131316 (2014).","journal-title":"J. Nutr. Biochem."},{"key":"20052_CR53","doi-asserted-by":"publisher","first-page":"E211","DOI":"10.1152\/ajpendo.91014.2008","volume":"297","author":"G Yang","year":"2009","unstructured":"Yang, G. et al. Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome. Am. J. Physiol. Endocrinol. Metab. 297, E211\u201324 (2009).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"20052_CR54","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/j.bbadis.2016.05.001","volume":"1862","author":"EH Schuchman","year":"2016","unstructured":"Schuchman, E. H. Acid ceramidase and the treatment of ceramide diseases: the expanding role of enzyme replacement therapy. BBA - Molecular Basis of Disease. 1862, 1459\u20131471 (2016).","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease"},{"key":"20052_CR55","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1089\/hum.2010.195","volume":"22","author":"JS Walia","year":"2011","unstructured":"Walia, J. S. et al. Autologous Transplantation of Lentivector\/Acid Ceramidase\u2013Transduced Hematopoietic Cells in Nonhuman Primates. Hum. Gene Ther. 22, 679\u2013687 (2011).","journal-title":"Hum. Gene Ther."},{"key":"20052_CR56","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ymgme.2008.08.003","volume":"95","author":"S Ramsubir","year":"2008","unstructured":"Ramsubir, S. et al. In vivo delivery of human acid ceramidase via cord blood transplantation and direct injection of lentivirus as novel treatment approaches for Farber disease. Mol. Genet. Metab. 95, 133\u2013141 (2008).","journal-title":"Mol. Genet. Metab."},{"key":"20052_CR57","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1089\/10430349950018003","volume":"10","author":"JA Medin","year":"1999","unstructured":"Medin, J. A. et al. Retrovirus-mediated correction of the metabolic defect in cultured Farber disease cells. Hum. Gene Ther. 10, 1321\u20131329 (1999).","journal-title":"Hum. Gene Ther."},{"key":"20052_CR58","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1084\/jem.187.4.601","volume":"187","author":"B Lu","year":"1998","unstructured":"Lu, B. et al. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J. Exp. Med. 187, 601\u2013608 (1998).","journal-title":"J. Exp. Med."},{"key":"20052_CR59","doi-asserted-by":"crossref","unstructured":"Bielawski, J. et al. Sphingolipid analysis by high performance liquid chromatography-tandem mass spectrometry (HPLC-MS\/MS). Sphingolipids as Signaling and Regulatory Molecules 46\u201359 (2010).","DOI":"10.1007\/978-1-4419-6741-1_3"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-20052-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-20052-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-20052-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T17:29:15Z","timestamp":1693502955000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-20052-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,29]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["20052"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-20052-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,29]]},"assertion":[{"value":"21 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"1808"}}